Cancer Research | Apr. 15, 2019 Estrogen Receptor Covalent Antagonists: The Best Is Yet to Come The development of tamoxifen and subsequent estrogen receptor alpha (ERα) antagonists represents a tremendous therapeutic breakthrough in the treatment of… Read More